Praxsyn (PXYN) Stock Overview

A health care company, provides medical practitioners with medications and services for their patients. More details

PXYN fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Latest financial reports are more than a year old

High level of non-cash earnings

Does not have a meaningful market cap ($847)

PXYN Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Praxsyn Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Praxsyn
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.000001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	0%
3 Year Change	0%
5 Year Change	-99.80%
Change since IPO	-99.90%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	PXYN	US Pharmaceuticals	US Market
7D	0%	-1.1%	-2.0%
1Y	0%	28.6%	11.2%

Return vs Industry: PXYN underperformed the US Pharmaceuticals industry which returned 28.6% over the past year.

Return vs Market: PXYN underperformed the US Market which returned 11.2% over the past year.

Price Volatility

Is PXYN's price volatile compared to industry and market?
PXYN volatility
PXYN Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.7%
Market Average Movement	6.4%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	2.9%

Stable Share Price: PXYN's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine PXYN's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2005	n/a	Sean Daly	www.praxsyn.com

Praxsyn Corporation, a health care company, provides medical practitioners with medications and services for their patients. It formulates non-narcotic and non-habit forming medications using therapeutic and preventative agents in the forms of transdermal creams, patches, and oral capsules for pain management, erectile dysfunction, and metabolic therapies. Praxsyn Corporation provides its products to patients covered under the California workers’ compensation system, as well as preferred provider contracts.

Praxsyn Corporation Fundamentals Summary

How do Praxsyn's earnings and revenue compare to its market cap?
PXYN fundamental statistics
Market cap	US$847.00
Earnings (TTM)	US$6.91m
Revenue (TTM)	US$63.50m

0.0x

P/E Ratio

0.0x

P/S Ratio

Is PXYN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PXYN income statement (TTM)
Revenue	US$63.50m
Cost of Revenue	US$7.23m
Gross Profit	US$56.27m
Other Expenses	US$49.36m
Earnings	US$6.91m

Last Reported Earnings

Sep 30, 2015

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did PXYN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/01/21 19:19
End of Day Share Price	2026/01/14 00:00
Earnings	2015/09/30
Annual Earnings	2014/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Praxsyn Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.